Clinical trials
Observational Vitiligo trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 22 |
| Recruiting | 7 |
| Not yet recruiting | 6 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 8 |
| Cairo University | 5 |
| Momentum Data | 4 |
| Xijing Hospital | 3 |
| St. Luke's-Roosevelt Hospital Center | 2 |
| Target PharmaSolutions, Inc. | 2 |
| Air Force Military Medical University, China | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Aswan University | 1 |
| Benha University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vitiligo | 65 |
| Psoriasis | 15 |
| Dermatitis, Atopic | 14 |
| Alopecia Areata | 12 |
| Hidradenitis Suppurativa | 7 |
| Graves Disease | 5 |
| Acne Vulgaris | 4 |
| Autoimmune Diseases | 4 |
| Celiac Disease | 4 |
| Colitis, Ulcerative | 4 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.